Next Article in Journal
Different Sensitivity Levels of the Photosynthetic Apparatus in Zea mays L. and Sorghum bicolor L. under Salt Stress
Next Article in Special Issue
Phytochemical Analyses, Antioxidant and Anticancer Activities of Ethanolic Leaf Extracts of Moringa oleifera Lam. Varieties
Previous Article in Journal
Genetic and Molecular Control of Somatic Embryogenesis
Previous Article in Special Issue
Pharmacological Exploration of Phenolic Compound: Raspberry Ketone—Update 2020
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 10
Issue 7
10.3390/plants10071468
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Euphorbia characias: Phytochemistry and Biological Activities

by
Antonella Fais
†,
Giovanna Lucia Delogu
†,
Sonia Floris
,
Benedetta Era
,
Rosaria Medda
* and
Francesca Pintus
Department of Life and Environmental Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Plants 2021, 10(7), 1468; https://doi.org/10.3390/plants10071468
Submission received: 10 June 2021 / Revised: 12 July 2021 / Accepted: 13 July 2021 / Published: 17 July 2021
(This article belongs to the Special Issue Research of Bioactive Substances in Plant Extracts)
Browse Figures
Versions Notes

Abstract

:
The aim of this review is to summarize all the compounds identified and characterized from Euphorbia characias, along with the biological activities reported for this plant. Euphorbia is one of the greatest genera in the spurge family of Euphorbiaceae and includes different kinds of plants characterized by the presence of milky latex. Among them, the species Euphorbia characias L. is an evergreen perennial shrub widely distributed in Mediterranean countries. E. characias latex and extracts from different parts of the plant have been extensively studied, leading to the identification of several chemical components such as terpenoids, sterol hydrocarbons, saturated and unsaturated fatty acids, cerebrosides and phenolic and carboxylic acids. The biological properties range between antioxidant activities, antimicrobial, antiviral and pesticidal activities, wound-healing properties, anti-aging and hypoglycemic properties and inhibitory activities toward target enzymes related to different diseases, such as cholinesterases and xanthine oxidase. The information available in this review allows us to consider the plant E. characias as a potential source of compounds for biomedical research.

1. Introduction

Euphorbiaceae is one of the largest flowering plant families, which is widely distributed in the world, especially in the tropical and temperate regions, and comprises about 300 genera and 8000 species [1]. The classification of Euphorbiaceae was revealed to be difficult due to the variability of habitat, morphology and genetics. This family showed a rich variety of chemical substances, especially rich in alkaloids and terpenoid compounds, and several potentially medicinal properties [2,3]. The genus Euphorbia comprises different kinds of plants, such as trees, lianas, herbs and shrubs. These plants are characterized by the presence of milky latex sap contained inside the laticifers, single specialized cells or articulated series of cells that permeate various tissues of the plant. Latex is a complex emulsion which consists of lipids, rubber, resin, starch and a variety of different proteins and enzymes. The physiological function of the latex is not completely known but it probably has a role as a water and nutrition reserve, and it seems to be involved in plant defense against phytopathogens and in sealing wounded areas [4].
Among Euphorbiaceae, the species Euphorbia characias L. is an evergreen perennial shrub up to about 1.5 m tall, with a bushy habit, widely distributed in Mediterranean countries. The inflorescence has a unique structure called the ‘cyathia’ which is arranged in rays growing from the bases of leaves. Leaves have a lanceolate structure 15 cm long, arranged along the stems. Latex permeates through all the plant and mainly exudes from the cut stems (Figure 1).
E. characias latex has been extensively studied and several proteins have been isolated and characterized. Among them, an enzyme named Euphorbia latex peroxidase (ELP) has been the object of numerous research papers due to its peculiar characteristics. This is a calmodulin-binding protein and its activity is therefore finely regulated by calcium ions. The presence of these ions, in addition to increasing the enzymatic activity, can even direct ELP towards different catalytic pathways using the same substrate [5]. A copper/TPQ-containing amine oxidase is also a part of the complex machinery of E. characias latex and the characterization of this enzyme made it possible to discover the key role of specific amino acids and domains in modulating substrate access into the active site of plant and mammalian amine oxidases [6]. Moreover, other enzymes have been purified and characterized and several nucleotide sequences are present in the GenBank database [7,8,9].
In recent years, scientists have made a great contribution to reporting the chemical constituents and biological properties of E. characias. However, there is no systematic review available that covers the important aspects of this plant, such as its non-protein composition. In order to provide new information for in-depth exploration and full use of this plant, we systematically and critically summarized the current findings on the non-protein compounds identified and characterized from E. characias. Furthermore, the biological activities of the isolated compounds or the tested extracts are also reported. The information available on this plant, reported in this review, allows us to explore their therapeutic potential, highlight gaps and provide the scientific basis for future study of this plant.

2. Chemical Constituents

Many chemical compounds with different structures have been identified and isolated from E. characias. In the following subsections, all these compounds, together with their nomenclature, are reported. The chemical structure of most of the compounds is reported to get an overview of the compounds with the structure immediately available, avoiding the well-known structure of compounds such as sugars, alkanes, alkenes or fatty acids. The reported molecules were identified from different parts of the plant (for example, in leaves, stems, latex, flowers or seeds) and the localization of each compound is also reported.

2.1. Terpenoids, Sterol Hydrocarbons, Fatty Acids and Cerebrosides

Terpenes are a class of hydrocarbon secondary metabolites, and their structure is built up from five-carbon isoprene units linked together. A rich diversity of structural classes of terpenes depend on different configuration degrees of unsaturation, oxidation, ring closures and functional groups. Terpenoids are primarily found in a wide variety of higher plants [10]. The terpenes and terpenoids are classified in hemiterpenes (1), monoterpenes (2), sesquiterpenes (3), diterpenes (4), sesterterpenes (5), triterpenes (6) and polyterpenes (many units), based on the number of isoprene units they present.
Polycyclic diterpenoids have been found in several plants of Euphorbia species and represent one of the major components of the lipid fraction [11]. In 2000, Appendino and colleagues identified 13 oxygenated diterpenoids from E. characias [12]. These compounds were isolated from an acetone extract from leaves and stems of the plant. Moreover, another two diterpenoid compounds were identified in the hexane extract of the latex. Table 1 shows the structure of these compounds which are abietane (compounds 1–6), atisane (compounds 7–9), kaurene (compound 10), pimarane (compounds 11–13) and cembrane (compound 15)-type diterpenoids. Diterpenes are important as natural products for potential applications as pharmacological agents in drug discovery due to their wide range of biological activities. In fact, antitumor, antimicrobial and anti-inflammatory activities are only some of the reported biological activities of this class of molecules [13]. Helioscopinolides A (4) and B (5) have displayed relevant activity against Staphylococcus aureus and a modest antibacterial property against Moraxella catarrhalis was previously found for helioscopinolide A [14]. Moreover, the ent-abietane compounds showed meaningful up-regulated expressions of matrix metalloproteinases [15], which not only have a role in the resolution phase of wound healing but also affect other responses linked to wound healing, such as re-epithelization and inflammation [16]. In a previous work [17], compound 10 (16β,17-dihydroxy-ent-kauran-3-one) was found to be cytotoxic at concentrations ranging from 2 to 50 µg/mL.
In 1983 and in 1984, Seip and Hecker isolated different lathyrane (16a–f) and jatrophane-type (17a–h) compounds from the acetone extract of E. characias latex [19,20], and the relative structures are reported in Table 2.
Lathyranes represent one of the main groups of tricyclic diterpenes with a 5, 11 and 3-membered ring system. These diterpenes may be considered derived from the hydrocarbon nucleus of casbane and its unsaturated analogue casbene. The fusion of rings A and B may have the configuration trans or cis; usually trans between rings A and B and cis between B and C. They may contain an epoxy function and double bonds.
Jatrophane diterpeses are macrocyclic compounds with a bicyclo[10.3.0]pentadecane skeleton, without the cyclopropane ring of lathyranes. Their structures vary for the configuration of the diterpene core, the number and position of the double bonds and the number of oxygen functions, which can be hydroxy, keto, epoxy, ether and ester groups. Natural jatrophane diterpenes, occurring exclusively in the Euphorbiaceae family, are in general polyacylated derivatives in which the acetyl, benzoyl, isobutanoyl, 2-methylbutanoyl or nicotinoyl are the acyl residues most frequently bounded.
Twelve new diterpenes were isolated from the whole plant. These compounds are based on a jatrophane skeleton and named euphocharacins a–l (18a–l) (Table 2) [21]. The biological activity of these compounds isolated from an ethyl acetate extract is reported as inhibition of the daunomycin-efflux activity of P-glycoprotein from cancer cells [22].
Triterpenes are also predominant structures among the secondary metabolites identified in latex extract. Cycloartenol (21), 24-methylenecycloartenol (22), lanosterol (24) and lupeol (28) were found in significant amounts, but the major constituent was butyrospermol (25). Obtusifoliol (31), ergostadienol (32) and squalene (19) were present but in lower quantities. In the category of sesquiterpenes, cedrene (33), junipene (34), cadinene (35) and germacrene (36) were also identified [18]. Squalene and its derivatives, as well as other sterol compounds, were also identified in extracts from other sources, as reported in Figure 2.
In seeds of E. characias, the major lipids are neutral lipids, most of which are triacylglycerols, representing 80–97% of the total lipids [23]. The fatty acids identified in E. characias were myristic, palmitic, palmitoleic, stearic, oleic, vaccenic, linoleic, linolenic and arachidic acid (compounds 38–46) [23,24,25,26]. Considering the literature, the published data about fatty acids composition present slightly differences, but it is clear that unsaturated fatty acids are more dominant than saturated in seeds [23,24]. Leaves showed a higher presence of linolenic acid (18:3) [23,25]. Moreover, oleic acid (18:1) is the major component of elaiosome and a role of this fatty acid in myrmecochory, by acting as a chemical cue for ants, has been proposed [26].
Cerebrosides represent a member of the sphingolipid class of lipids, which are also known to be distributed in Euphorbiaceae latex.
Nine cerebrosides were isolated and purified from the latex of E. characias (compounds 47–55) (Table 3). Structurally, these cerebrosides are composed of a 1-O-β-d-glucopyranoside linked to a polyhydroxy sphingosine and a 2-hydroxy saturated or unsaturated fatty acid.

2.2. Phenolic and Carboxylic Acid Compounds

Phenolic and polyphenolic compounds are a large group of chemical substances with various chemical structures and activities. Chemically, they contain an aromatic ring with one or more hydroxyl groups, and they comprise simple molecules, such as phenolic acids, and more complex compounds, such as flavonoids. Phenolic and polyphenolic compounds are widely disseminated in the plant kingdom and constitute one of the most significant groups of secondary metabolites of plants, showing numerous bioactive properties, the most important being the antioxidant activity.
The chromatographic profile of a trichloroacetic acid (TCA) E. characias latex extract showed the presence of several carboxylic acids (aromatic and aliphatic) and alcoholic compounds [30]: benzoic acid (56), cinnamic acid (57), 4-hydroxybenzylalcohol (58), tyrosol (59), vanillic acid (60), p-coumaric acid (61), ferulic acid (62), sinapic acid (63), caffeic acid (64), 2-hydroxypropanoic acid (65), 2,3-dihydroxypropanoic acid (66), 3-hydroxypropanoic acid (67), 2-hydroxy-3-methylbutanoic acid (68), 4-hydroxybutanoic acid (69), 2-hydroxyesanoic acid (70), 3-phenylpropenoic acid (71) and 3-hydroxy-3-phenylpropenoic acid (72).
Furthermore, some flavonoids were identified in latex but especially in aerial parts of the plant. Flavonoids represent one of the major and ubiquitous pigments in plants. They are composed of two aromatic rings (A and B) linked by an oxygenated heterocycle (C).
These secondary metabolites were mainly quercetin glycosides: quercetin-3-O-glucoside, quercetin-3-xyloside, quercetin-3-arabinoside, quercetin-3-rhamnoside (quercitrin), quercetin-3-(2-O-acetyl)arabinofuranoside, quercetin-3-O-galactoside and their precursor quercetin (74–80) (Figure 3). Other compounds, such as gallic acid, catechin, myricetin derivatives and ellagic acid derivatives, were identified in E. characias ethanolic extracts from leaves. Quercetin-3-(2-O-acetyl)arabinofuranoside (79) was the most abundant compound in ethanolic extract of both leaves and flowers, followed by quercetin-3-O-rhamnoside and quercetin-3-O-arabinoside (78,77) [31,32].
Wound-healing activity was reported for the methanolic extract of the aerial parts of E. characias subsp. wulfenii [33]. The combined activity of the constituents present in the extract, especially flavonoids such as guaijaverin 77, quercitrin 78 and hyperoside 80, seemed to be responsible of this effect. Biological activities of ethanolic extracts from leaves and flowers were also reported (see Section 3).
Finally, in the aerial parts of the plant, alkanes (90–101), alcohols (102–107), aldehydes (108–113), ketones (114, 115) α-tocopherol (116), carboxylic acids (117, 118) and sugars (119, 121) were also identified (Table 4). Several of these metabolites change their concentrations in relation to the three phenological stages of the plant (preflowering, flowering and postflowering).

2.3. Natural Rubber and Rubber Particles

Natural rubber is an important polymer produced by numerous plants. The physiological role of rubber is not fully recognized, but it seems to be involved in disease resistance, wound healing or tolerance to environmental stress [35]. The main source of commercial natural rubber, at present, is the latex of Hevea brasiliensis, a member of the Euphorbiaceae family. This rubber has a characteristic high molecular weight (>1 million Da) and properties that are difficult to obtain with synthetic processes. Otherwise, the use of products (gloves or other medical devices) made from this natural rubber could cause an allergic reaction in sensitized persons. Two other plants seem to be a possible alternative to H. brasiliensis: Parthenium argentatum (Guayule) and Taraxacum kok-saghyz. However, new sources of natural rubber are needed [36].
A natural rubber from the latex of E. characias was identified, extracted and characterized [37]. This polymer was extracted by different methods, the better being extraction with acetic acid followed by treatment with cyclohexane and ethanol with a yield of 14.3% (w/v) of plant latex. It showed a low molecular weight of 93,000 Da and was revealed to have a cis-1,4-polyisoprene structure, typical of natural rubber. This low molecular weight rubber is different to that of H. brasiliensis, but it is similar to other Euphorbiaceae, such as Euphorbia etherophylla and Euphorbia lactiflua [38].
In latex-producing plants, the rubber biosynthesis occurs in the latex of laticifers, and rubber is compartmentalized in microscopic rubber particles constituted by a core of rubber encircled by a monolayer membrane and membrane-bound proteins [36]. Rubber particles of E. characias are spherical in shape with a diameter ranging from 0.02 to 1.2 mm, as observed by scanning electron microscopy [39]. The membrane-bound cis-prenyltransferase enzyme (“rubber transferase”, E.C. 2.5.1.20), which is the key enzyme in natural rubber biosynthesis, was identified in E. characias rubber particles, and the nucleotide and predicted amino acid sequence was determined [39].

3. Biological Activities

The biological activities of E. characias extracts are reported in the following subsections. Some extracts showed potential as sources of inhibitors of target enzymes related to different diseases, and the IC50 values are reported in Table 5. The activities of the compounds identified in the active extracts are also reported in Table 6.

3.1. Anti-Aging Properties

Tyrosinase, elastase and collagenase are some of the target enzymes in aging treatment or prevention. Tyrosinase (EC 1.14.18.1) is the key enzyme in the synthesis of melanin biopolymers. Melanin is produced in melanocytes by numerous enzymatic and non-enzymatic reactions. The first step is the conversion of tyrosine in 3,4-dihydroxyphenylalanine (l-DOPA) by a reaction of hydroxylation, followed by oxidation of l-DOPA to o-dopaquinone. These two reactions are catalyzed by tyrosinase and represent the rate-limiting step in melanin production. The subsequent steps involve oxidation and polymerization reactions and the action of other enzymes, such as the tyrosinase-related proteins. Melanin has an important skin photoprotective role, being able to absorb UV radiation and protect cells and tissues from the toxic effects of this radiation. However, inhibition of melanogenesis is particularly important on two fronts: cosmetics and medicine. An excess of melanin production can cause hyperpigmentation-related disorders such as melasma, age spots and freckles.
Extracts from E. characias aerial parts showed antimelanogenic properties. Among them, leaves ethanolic extracts showed the best activities (Table 5). Mushroom tyrosinase activity was inhibited with an IC50 of 34 µg/mL. The extract also showed antimelanogenic activity, inhibiting cellular tyrosinase activity by 47% and 57% at 50 and 100 µg/mL, respectively, using the B16F10 cellular model. A stronger effect than the standard compound, kojic acid, was determined [79]. As reported in Table 6, some of the compounds identified in flower and leaf ethanolic extracts of E. characias exhibited a well-documented inhibitory activity toward tyrosinase.
Quercitrin and two other quercetin derivatives were isolated from the methanolic extract of aerial parts of E. characias subsp. wulfenii, and these compounds were found to significantly inhibit elastase and collagenase activities [33]. Inhibition of these enzymes is linked with a wound-healing effect (see the next section “In vivo wound-healing activity”) and skin-aging prevention. Elastase (EC 3.4.21.36) and collagenase (EC3.4.24.3) are indeed enzymes that degrade the proteins elastin and collagen, involved in the elasticity and structure of the extracellular matrix. Thus, inhibition of these enzymes contributes to the prevention of wrinkle formation, characteristic of the skin-aging process.

3.2. In Vivo Wound-Healing Activity

In traditional medicine, E. characias latex and aerial parts are used to treat wounds. Significant wound-healing activity was reported from extracts of E. characias subsp. wulfenii. Active constituents were identified in methanolic extracts: quercetin-3-O-rhamnoside, quercetin-3-O-galactoside and quercetin-3-O-arabinoside. These compounds were present in extracts of the aerial parts of plant in different concentrations. These three phytoconstituents could be responsible for the wound-healing potential of the plant extract. Quercetin-3-O-rhamnoside was shown to be the most abundant compound in this extract of E. characias subsp. wulfenii [33]. Quercetin-3-O-rhamnoside and quercetin-3-O-arabinoside were also identified in alcoholic extracts of the leaves and stems of E. characias subsp. characias. In all extracts, quercetin-3-O-rhamnoside was the most abundant compound [25,31]. Bacterial infections or an over-production of reactive oxygen species (ROS) can reduce the process of wound healing. This process may be improved using antioxidant and antibacterial agents. The alcoholic extracts, fractions and isolated compounds from aerial parts of E. characias exhibited antimicrobial and antioxidant activities. Furthermore, the aerial parts of E. characias subsp. wulfenii possess anti-inflammatory activities [31,33]. Tsatsop Tsague et al. (2020) [80] reported the antioxidant and antimicrobial activities of quercetin-3-O-rhamnoside, one of the main compounds identified in aerial parts of E. characias species. Furthermore, quercetin-3-O-arabinoside was described to have antibacterial activity against Bacillus cereus and Salmonella enteritidis [81].
The quercetin glycosides mentioned above also showed collagenase and elastase enzyme inhibitory activity. In wound repair, collagenase and elastase activity catalyze the turn-over and restructuring of matrix components, which is a significant event in wound repair. These quercetin glycosides, with their activities, could contribute to the wound-healing activity shown by the extracts of the plant. All of this evidence supports the ethnomedicine use of the aerial parts of E. characias in folk medicine.

3.3. Cholinesterases Inhibition

Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) are enzymes associated with the pathology of Alzheimer’s disease (AD). In fact, one of the main causes linked to the onset of AD is the lack of acetylcholine. This neurotransmitter is hydrolyzed by both AChE and BChE, whose activities are enhanced in AD condition. Thus, the inhibition of these enzymes, enhancing the level of the neurotransmitter acetylcholine, represent one of the strategies in AD treatment.
Latex and aerial part extracts of E. characias were tested for their cholinesterase inhibition. Leaves, stems and flowers were extracted with water and ethanol and, as seen also from other enzyme inhibitions, the alcoholic extracts showed the best activity. The best result was obtained with leaves ethanolic extract on both cholinesterases, but it was more effective against BChE, even if the IC50 value was higher than the reference compound galantamine (Table 5). Latex extracted with trichloroacetic acid was tested only against AChE and showed good inhibition [30]. Analysis of latex composition showed the presence of several acid and phenolic compounds. Some of these compounds are reported to be AChE inhibitors, such as compounds 57 and 60–64 [82,83,84].
Table 6 reports some of the compounds identified in flower and leaf ethanolic extracts of E. characias, showing documented inhibitory activity against cholinesterase enzymes. The most present compounds in those extracts are the derivatives of quercetin and, among them, only the quercetin rhamnoside shows inhibitory activity against AChE (Table 6).

3.4. Xanthine Oxidase Inhibition

The purine metabolism in humans leads to the formation of uric acid. This final product, excreted in urine, is formed by the oxidation catalyzed by Xanthine oxidase (XO, EC 1.2.3.2) of hypoxanthine and xanthine, with concomitant production of ROS. The accumulation of uric acid results from an overproduction, due to an increased purine ingestion and metabolization, or from a decrease in its urinary excretion. Crystals of uric acid deposit in the joints, mostly in knee, elbow and ankle, causing severe pain and inflammation, and are responsible for the pathogenesis of gout. In order to control uric acid deposition, XO has been used as a therapeutic target, and its inhibitors are therefore used in the treatment of hyperuricemia and gout. Since XO is also a pro-oxidant enzyme, inhibitors with antioxidant activities are of much interest.
Inhibitory activity of leaves and flowers of E. characias was reported [32]. Only ethanolic extracts showed enzyme inhibition, which was higher than the standard inhibitor allopurinol (Table 5). Some of the compounds identified in flower and leaf ethanolic extracts of E. characias with a referred inhibitory activity against XO are reported in Table 6.

3.5. Hypoglycemic Properties

Hyperglycemia is a condition of an excessive amount of glucose in the blood serum, which may be associated with diabetes and related cardiovascular diseases. It requires emergency treatment. One of the main therapeutic strategies to treat diabetes is to decrease postprandial hyperglycemia by the inhibition of carbohydrate hydrolyzing enzymes, such as α-amylase and α-glucosidase. These enzymes break down complex carbohydrates and disaccharides to glucose, which is absorbed in the bloodstream. α-amylase (EC 3.2.1.1) is a key enzyme that catalyzes the endo-hydrolysis of α-d-(1, 4) glycosidic linkages in dietary starch, glycogen and carbohydrates with three or more glucose units. The oligosaccharides produced by α-amylase reaction are then degraded to free D-glucose by α-glucosidase (EC 3.2.1.3) in the small intestine. Thus, inhibition of these enzymes can suppress carbohydrate digestion, reduce glucose uptake and consequently, it may be helpful to reduce the postprandial glucose levels. Several enzyme inhibitors have been approved as antidiabetic drugs, such as acarbose and miglitol, but they induce side effects, and the identification of novel potential inhibitors is of great interest. Presently, only aerial parts of E. characias were tested for these activities and the results are encouraging for further investigation [32]. Both the enzymes are inhibited by plant extracts, but the best effect is showed against α-glucosidase. The α-glucosidase inhibitory activity of the ethanolic extracts was therefore found to be about 100 times higher than the standard compound acarbose (Table 6). Kinetic analysis showed that both extracts from leaves and flowers act as noncompetitive inhibitors against α-amylase, while mode of inhibition on α-glucosidase revealed that leaves and flowers act as noncompetitive and uncompetitive inhibitors, respectively. Moreover, it is noteworthy that the therapeutic drugs usually used for the treatment of hyperglycemia in diabetic patients, such as acarbose, show side effects probably correlated with a more significant inhibition of a-amylase if compared to α-glucosidase inhibition [85]. Leaf and flower ethanolic extracts showed a ratio between α-amylase and α-glucosidase inhibition higher than the ratio of acarbose, marking these extracts as good candidates for further study.
Table 6 reports the compounds identified in flower and leaf ethanolic extracts of E. characias showing documented inhibitory activity against α-amylase and α-glucosidase.

3.6. Antioxidant Activity

The biological activities highlighted for Euphorbia species included antioxidant activity. In these species, there is a vast number of different types of antioxidant compounds that could have a key role in preventing free radical chain reactions. Free radicals cause grave cell and tissue damage, which is the main cause of the aging process and the pathogenesis of several diseases.
The analysis of TCA extract of E. characias latex has highlighted high antioxidant activity; a higher amount of antioxidants was detected using ABTS+• instead of DPPH• assay [30]. Pintus et al. (2010) [4] reported, in E. characias latex, the presence of proteins that act as antioxidant enzymes. The antioxidant molecules and enzymatic proteins could act contemporarily as mechanisms of defense in the plant [30]. The activities of aqueous and alcoholic extracts from aerial parts of E. characias were evaluated with different assays. Leaf ethanolic extract exhibited significantly higher free radical scavenging activity if compared with aqueous extracts [31]. Moreover, leaf and flower ethanolic extracts showed no cytotoxic activity and inhibited H2O2-induced ROS generation in a cellular system [32]. Several compounds identified in E. characias are well-known antioxidant molecules [86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107] which could be responsible for the activity detected in the extracts.

3.7. Antiviral, Antimicrobial and Pesticidal Activities

The demand for bioactive compounds from natural sources is continuously increasing, because antibiotics and their extensive use led to the emergent problem of the multidrug resistance of microorganisms related to antibiotics and their extensive use. Several studies reported plant antimicrobials efficacy towards a great number of pathogens and food-borne agents that can cause viral infections and several diseases. In this context, aqueous and alcoholic extracts from aerial parts of E. characias have been investigated for their antiviral and antimicrobial efficacy. With regard to the antiviral effect, activities against the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase-(RT-) associated RNA-dependent DNA polymerase (RDDP) and Ribonuclease H (RNase H) were evaluated. These activities are crucial for viral replication, and therefore they represent important drug targets for which there is a need for new drugs. All the extracts possessed anti-HIV activity and among them, ethanolic extracts were more active than aqueous extracts, and the ethanolic extract from flowers seemed to be the most effective inhibitor of HIV-1 RT-associated RNA-dependent DNA polymerase and Ribonuclease H. Among the compounds identified in flower and leaf ethanolic extracts of E. characias, compounds 74, 78, 81, 84 and 89 showed documented HIV inhibitory activity [108,109,110,111].
Moreover, E. characias extracts were tested in order to evaluate an antagonistic activity against a panel of microorganisms: Staphylococcus aureus, Bacillus cereus, Listeria monocytogenes, Escherichia coli, Salmonella typhimurium, Candida albicans, Saccharomyces cerevisiae, Aspergillus flavus and Penicillium chrysogenum. Extracts from leaves appeared to possess the best antibacterial activity, followed by flower and stem extracts. Ethanolic extracts from leaves displayed the highest antibacterial activity towards all the tested Gram-positive bacteria: B. cereus, L. monocytogenes and S. aureus [31]. Among the compounds identified in this extract, antibacterial activity versus S. aureus was reported for compounds 75, 77, 81, 82 and 84 [112,113,114,115,116]. Activity against L. monocytogenes and B. cereus was reported for compounds 77, 81 and 82 [113,115,117] and 75 and 81 [112,114], respectively.
In addition to these properties, the antifungal activity of crude latex extract was reported [118]. The antifungal effect of plant latex seems to be related to the action of lysosomal hydrolases. These enzymes can be responsible for cell wall degradation, which results in a better entrance of antifungal drugs from extracellular medium. The concomitant use of latex and antifungal drugs may reduce the dose of drugs in the treatment of mycoses, therefore decreasing their side effects. E. characias latex showed an antifungal effect, alone and in combination with the synthetic imidazole drug, ketoconazole [118].
Plant chitinases exert a significant role in plant defense, acting on chitin-containing pathogens, and they also show antimicrobial, antiviral and insecticidal properties. In recent years, a chitinase was identified and purified from E. characias latex (ELC) [9]. ELC proved to be an effective management strategy against the insect Drosophila suzukii, which has recently caused important economic losses in Europe due to their attacks on developing soft fruits, by degrading the chitin exoskeleton of D. suzukii. Moreover, ELC at concentrations that were harmless to the host plants could be considered an environmentally friendly alternative to chemical pesticides, opening the door to develop sustainable agriculture [119].

4. Conclusions

Plant products are still major sources of innovative therapeutic agents, and since ancient times they have been widely used to treat many diseases, such as cancer, diabetes and cardiovascular and neurodegenerative diseases. Bioactive compounds from natural sources, as an alternative to synthetic molecules, are increasingly in demand, since they provide unlimited opportunities for new drug discoveries because of the unmatched availability of chemical diversity. In addition to the identification of new molecules with biological properties, there is growing evidence that known molecules are finding new applications through better understanding of molecular biology and clinical observations.
E. characias, cited in most ancient treatises of Greek and Latin medicine, is one of the oldest known medicinal plants of the Western tradition. The different phytochemicals, produced in the latex, seeds, steams, leaves and flowers of this plant, are terpenoids, sterol hydrocarbons, fatty acids, cerebrosides and phenolic and carboxylic acid compounds. In addition to these compounds, E. characias latex contains a low-molecular-weight natural rubber.
The E. characias biological properties reported in this review allow us to consider its wide potential therapeutic application. Indeed, it represents a source of inhibitors of target enzymes related to different oxidative stress-related diseases such as diabetes, Alzheimer’s and hyperpigmentation disorders, as well as microbial and viral infections. Once the bioactive compounds are identified, future prospects include further studies through in vitro and in vivo approaches in order to develop new, effective drugs. Moreover, vehiculation of active compounds represents an emerging technology and could be used to improve the delivery and efficacy of these compounds.
Although the plant E. characias needs additional physicochemical and chemical analyses, and a majority of its phytochemicals require further in-depth characterization for their therapeutic efficacy and safety, we believe that this review may contribute to provide the scientific basis for future study and full use of this plant.

Author Contributions

Conceptualization, A.F., G.L.D., F.P. and R.M.; writing—original draft preparation, A.F, G.L.D., S.F., B.E., F.P. and R.M.; writing—review and editing, A.F, G.L.D., F.P. and R.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kemboi, D.; Peter, X.; Langat, M.; Tembu, J. A review of the ethnomedicinal uses, biological activities, and triterpenoids of euphorbia species. Molecules 2020, 25, 4019. [Google Scholar] [CrossRef]
  2. Mwine, J.T.; van Damme, P. Why do euphorbiaceae tick as medicinal plants? A review of euphorbiaceae family and its medicinal features. J. Med. Plants Res. 2011, 5, 652–662. [Google Scholar]
  3. Salehi, B.; Iriti, M.; Vitalini, S.; Antolak, H. Euphorbia-derived natural products with potential for use in health maintenance. Biomolecules 2019, 9, 337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Pintus, F.; Medda, R.; Rinaldi, A.C.; Spanò, D.; Floris, G. Euphorbia latex biochemistry: Complex interactions in a complex environment. Plant Biosyst. 2010, 144, 381–391. [Google Scholar] [CrossRef]
  5. Pintus, F.; Spanò, D.; Medda, R.; Floris, G. Calcium ions and a secreted peroxidase in Euphorbia characias latex are made for each other. Protein J. 2011, 30, 115–123. [Google Scholar] [CrossRef] [PubMed]
  6. Pintus, F.; Sabatucci, A.; Maccarrone, M.; Dainese, E.; Medda, R. Amine oxidase from Euphorbia characias: Kinetic and structural characterization. Biotechnol. Appl. Biochem. 2018, 65, 81–88. [Google Scholar] [CrossRef]
  7. Pintus, F.; Spano, D.; Corongiu, S.; Floris, G.; Medda, R. Purification, primary structure, and properties of Euphorbia characias latex purple acid phosphatase. Biochemistry 2011, 76, 694–701. [Google Scholar] [CrossRef]
  8. Sabatucci, A.; Pintus, F.; Cabras, T.; Vincenzoni, F.; Maccarrone, M.; Medda, R.; Dainese, E. Structure of a nucleotide pyrophosphatase/phosphodiesterase (NPP) from Euphorbia characias latex characterized by small-angle X-ray scattering: Clues for the general organization of plant NPPs. Acta Crystallogr. Sect. D Struct. Biol. 2020, 76, 857–867. [Google Scholar] [CrossRef]
  9. Spanò, D.; Pospiskova, K.; Safarik, I.; Pisano, M.B.; Pintus, F.; Floris, G.; Medda, R. Chitinase III in Euphorbia characias latex: Purification and characterization. Protein Expr. Purif. 2015, 116, 152–158. [Google Scholar] [CrossRef] [PubMed]
  10. Tholl, D. Biosynthesis and biological functions of terpenoids in plants. Adv. Biochem. Eng. Biotechnol. 2015, 148, 63–106. [Google Scholar] [CrossRef]
  11. Shi, Q.W.; Su, X.H.; Kiyota, H. Chemical and pharmacological research of the plants in genus Euphorbia. Chem. Rev. 2008, 108, 4295–4327. [Google Scholar] [CrossRef]
  12. Appendino, G.; Belloro, E.; Cesare Tron, G.; Jakupovic, J.; Ballero, M. Polycyclic diterpenoids from Euphorbia characias. Fitoterapia 2000, 71, 134–142. [Google Scholar] [CrossRef]
  13. Vasas, A.; Hohmann, J. Euphorbia diterpenes: Isolation, Structure, biological activity, and synthesis (2008–2012). Chem. Rev. 2014, 114, 8579–8612. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Valente, C.; Pedro, M.; Duarte, A.; Maria, M.S.J.N.; Abreu, P.M.; Ferreira, M.J.U. Bioactive diterpenoids, a new jatrophane and two ent-abietanes, and other constituents from Euphorbia pubescens. J. Nat. Prod. 2004, 67, 902–904. [Google Scholar] [CrossRef] [PubMed]
  15. Yu, C.C.; Hsieh, C.R.; Hsiao, G.; Chen, P.Y.; Chang, M.L.; Yin, H.W.; Lee, T.H.; Lee, C.K. Regulated expressions of MMP-2, -9 by diterpenoids from Euphorbia formosana hayata. Molecules 2012, 17, 2082–2090. [Google Scholar] [CrossRef] [Green Version]
  16. Gill, S.E.; Parks, W.C. Metalloproteinases and their inhibitors: Regulators of wound healing. Int. J. Biochem. Cell Biol. 2008, 40, 1334–1347. [Google Scholar] [CrossRef] [Green Version]
  17. Gustafson, K.R.; Munro, M.H.G.; Blunt, J.W.; Cardellina, J.H.; McMahon, J.B.; Gulakowski, R.J.; Cragg, G.M.; Cox, P.A.; Brinen, L.S.; Clardy, J.; et al. HIV inhibitory natural products. 3. Diterpenes from Homalantus acuminatus and Chrysobalanus icaco. Tetrahedron 1991, 47, 4547–4554. [Google Scholar] [CrossRef]
  18. Christodoulakis, N.S.; Mamoucha, S.; Termentzi, A.; Fokialakis, N. Leaf structure and histochemistry of the hardy evergreen Euphorbia characias L. (Mediterranean spurge). Flora Morphol. Distrib. Funct. Ecol. Plants 2015, 210, 13–18. [Google Scholar] [CrossRef]
  19. Seip, E.H.; Hecker, E. Lathyrane type diterpenoid esters from Euphorbia characias. Phytochemistry 1983, 22, 1791–1795. [Google Scholar] [CrossRef]
  20. Seip, E.H.; Hecker, E. Derivatives of characiol, macrocyclic diterpene esters of the jatrophane type from Euphorbia characias. Phytochemistry 1984, 23, 1689–1694. [Google Scholar] [CrossRef]
  21. Corea, G.; Fattorusso, E.; Lanzotti, V.; Motti, R.; Simon, P.N.; Dumontet, C.; Di Pietro, A. Structure-activity relationships for euphocharacins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein. Planta Med. 2004, 70, 657–665. [Google Scholar] [CrossRef] [PubMed]
  22. Barile, E.; Corea, G.; Lanzotti, V. Diterpenes from Euphorbia as potential leads for drug design. Nat. Prod. Commun. 2008, 3, 1003–1020. [Google Scholar] [CrossRef] [Green Version]
  23. Carriere, F.; Chagvardieff, P.; Gil, G.; Pean, M.; Sigoillot, J.C.; Tapie, P. Fatty acid patterns of neutral lipids from seeds, leaves and cell suspension cultures of Euphorbia characias. Phytochemistry 1992, 31, 2351–2353. [Google Scholar] [CrossRef]
  24. Bruni, R.; Muzzoli, M.; Ballero, M.; Loi, M.C.; Fantin, G.; Poli, F.; Sacchetti, G. Tocopherols, fatty acids and sterols in seeds of four Sardinian wild Euphorbia species. Fitoterapia 2004, 75, 50–61. [Google Scholar] [CrossRef]
  25. Escrig, P.V.; Iglesias, D.J.; Corma, A.; Primo, J.; Primo-Millo, E.; Cabedo, N. Euphorbia characias as bioenergy crop: A study of variations in energy value components according to phenology and water status. J. Agric. Food Chem. 2013, 61, 10096–10109. [Google Scholar] [CrossRef] [PubMed]
  26. Boieiro, M.; Espadaler, X.; Gómez, C.; Eustaquio, A. Spatial variation in the fatty acid composition of elaiosomes in an ant-dispersed plant: Differences within and between individuals and populations. Flora Morphol. Distrib. Funct. Ecol. Plants 2012, 207, 497–502. [Google Scholar] [CrossRef]
  27. Palomino-Schätzlein, M.; Escrig, P.V.; Boira, H.; Primo, J.; Pineda-Lucena, A.; Cabedo, N. Evaluation of nonpolar metabolites in plant extracts by 13C NMR spectroscopy. J. Agric. Food Chem. 2011, 59, 11407–11416. [Google Scholar] [CrossRef]
  28. Falsone, G.; Cateni, F.; Katusian, F.; Wagner, H.; Seligmann, O.; Pellizer, G.; Asaro, F. New cerebrosides from Euphorbia characias. Z. Fur. Naturforsch. Sect. B J. Chem. Sci. 1993, 48, 1121–1126. [Google Scholar] [CrossRef] [Green Version]
  29. Falsone, G.; Cateni, F.; Baumgartner, M.; Lucchini, V.; Wagner, H.; Seligmann, O. Isolation and structure elucidation of five cerebrosides from Euphorbia characias L. Z. Fur. Naturforsch. Sect. B J. Chem. Sci. 1994, 49, 135–140. [Google Scholar] [CrossRef]
  30. Pintus, F.; Spanò, D.; Mascia, C.; Macone, A.; Floris, G.; Medda, R. Acetylcholinesterase inhibitory and antioxidant properties of Euphorbia characias latex. Rec. Nat. Prod. 2013, 7, 147–151. [Google Scholar]
  31. Pisano, M.B.; Cosentino, S.; Viale, S.; Spanò, D.; Corona, A.; Esposito, F.; Tramontano, E.; Montoro, P.; Tuberoso, C.I.G.; Medda, R.; et al. Biological activities of aerial parts extracts of Euphorbia characias. Biomed. Res. Int. 2016, 2016. [Google Scholar] [CrossRef] [Green Version]
  32. Fais, A.; Era, B.; Di Petrillo, A.; Floris, S.; Piano, D.; Montoro, P.; Tuberoso, C.I.G.; Medda, R.; Pintus, F. Selected enzyme inhibitory effects of Euphorbia characias extracts. Biomed. Res. Int. 2018, 2018. [Google Scholar] [CrossRef] [Green Version]
  33. Özbilgin, S.; Acıkara, Ö.B.; Akkol, E.K.; Süntar, I.; Keleş, H.; İşcan, G.S. In vivo wound-healing activity of Euphorbia characias subsp. wulfenii: Isolation and quantification of quercetin glycosides as bioactive compounds. J. Ethnopharmacol. 2018, 224, 400–408. [Google Scholar] [CrossRef] [PubMed]
  34. Fokialakis, N.; Melliou, E.; Magiatis, P.; Harvala, C.; Mitaku, S. Composition of the steam volatiles of six Euphorbia spp. from Greece. Flavour Fragr. J. 2003, 18, 39–42. [Google Scholar] [CrossRef]
  35. Cornish, K.; Blakeslee, J. Rubber Biosynthesis in Plants. Available online: https://lipidlibrary.aocs.org/chemistry/physics/plant-lipid/rubber-biosynthesis-in-plants (accessed on 15 July 2021).
  36. Cherian, S.; Ryu, S.B.; Cornish, K. Natural rubber biosynthesis in plants, the rubber transferase complex, and metabolic engineering progress and prospects. Plant Biotechnol. J. 2019, 17, 2041–2061. [Google Scholar] [CrossRef] [Green Version]
  37. Spanò, D.; Pintus, F.; Mascia, C.; Scorciapino, M.A.; Casu, M.; Floris, G.; Medda, R. Extraction and characterization of a natural rubber from Euphorbia characias latex. Biopolymers 2012, 97, 589–594. [Google Scholar] [CrossRef]
  38. Mekkriengkrai, D.; Ute, K.; Swiezewska, E.; Chojnacki, T.; Tanaka, Y.; Sakdapipanich, J.T. Structural characterization of rubber from Jackfruit and Euphorbia as a model of natural rubber. Biomacromolecules 2004, 5, 2013–2019. [Google Scholar] [CrossRef] [PubMed]
  39. Spanò, D.; Pintus, F.; Esposito, F.; Loche, D.; Floris, G.; Medda, R. Euphorbia characias latex: Micromorphology of rubber particles and rubber transferase activity. Plant Physiol. Biochem. 2015, 87, 26–34. [Google Scholar] [CrossRef]
  40. Chen, Q.X.; Kubo, I. Kinetics of mushroom tyrosinase inhibition by quercetin. J. Agric. Food Chem. 2002, 50, 4108–4112. [Google Scholar] [CrossRef] [PubMed]
  41. Xue, Y.L.; Miyakawa, T.; Hayashi, Y.; Okamoto, K.; Hu, F.; Mitani, N.; Furihata, K.; Sawano, Y.; Tanokura, M. Isolation and tyrosinase inhibitory effects of polyphenols from the leaves of persimmon, Diospyros kaki. J. Agric. Food Chem. 2011, 59, 6011–6017. [Google Scholar] [CrossRef] [PubMed]
  42. Fan, M.; Zhang, G.; Hu, X.; Xu, X.; Gong, D. Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanism. Food Res. Int. 2017, 100, 226–233. [Google Scholar] [CrossRef] [PubMed]
  43. Ademosun, A.O.; Oboh, G.; Bello, F.; Ayeni, P.O. Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities. J. Evid. Based Complement. Altern. Med. 2016, 21, NP11–NP17. [Google Scholar] [CrossRef]
  44. Khan, M.T.H.; Orhan, I.; Şenol, F.S.; Kartal, M.; Şener, B.; Dvorská, M.; Šmejkal, K.; Šlapetová, T. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem. Biol. Interact. 2009, 181, 383–389. [Google Scholar] [CrossRef] [PubMed]
  45. Jung, M.; Park, M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 2007, 12, 2130–2139. [Google Scholar] [CrossRef] [Green Version]
  46. Orhan, I.; Kartal, M.; Tosun, F.; Şener, B. Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z. Fur. Naturforsch. Sect. C J. Biosci. 2007, 62, 829–832. [Google Scholar] [CrossRef] [PubMed]
  47. Katalinić, M.; Bosak, A.; Kovarik, Z. Flavonoids as inhibitors of human butyrylcholinesterase variants. Food Technol. Biotechnol. 2014, 52, 64–67. [Google Scholar]
  48. Webster, G.L. Irritant plants in the spurge family (Euphorbiaceae). Clin. Dermatol. 1986, 4, 36–45. [Google Scholar] [CrossRef]
  49. Zhang, C.; Wang, R.; Zhang, G.; Gong, D. Mechanistic insights into the inhibition of quercetin on xanthine oxidase. Int. J. Biol. Macromol. 2018, 112, 405–412. [Google Scholar] [CrossRef] [PubMed]
  50. Oboh, G.; Ademosun, A.O.; Ayeni, P.O.; Omojokun, O.S.; Bello, F. Comparative effect of quercetin and rutin on α-amylase, α-glucosidase, and some pro-oxidant-induced lipid peroxidation in rat pancreas. Comp. Clin. Path. 2015, 24, 1103–1110. [Google Scholar] [CrossRef]
  51. Yuan, E.; Liu, B.; Wei, Q.; Yang, J.; Chen, L.; Li, Q. Structure activity relationships of flavonoids as potent α-amylase inhibitors. Nat. Prod. Commun. 2014, 9, 1173–1176. [Google Scholar] [CrossRef] [Green Version]
  52. Utari, F.; Itam, A.; Syafrizayanti, S.; Putri, W.H.; Ninomiya, M.; Koketsu, M.; Tanaka, K.; Efdi, M. Isolation of flavonol rhamnosides from Pometia pinnata leaves and investigation of α-glucosidase inhibitory activity of flavonol derivatives. J. Appl. Pharm. Sci. 2019, 9, 53–65. [Google Scholar] [CrossRef] [Green Version]
  53. Proença, C.; Freitas, M.; Ribeiro, D.; Oliveira, E.F.T.; Sousa, J.L.C.; Tomé, S.M.; Ramos, M.J.; Silva, A.M.S.; Fernandes, P.A.; Fernandes, E. α-Glucosidase inhibition by flavonoids: An in vitro and in silico structure–activity relationship study. J. Enzyme Inhib. Med. Chem. 2017, 32, 1216–1228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Wan-Nadilah, W.A.; Akhtar, M.T.; Shaari, K.; Khatib, A.; Hamid, A.A.; Hamid, M. Variation in the metabolites and α-glucosidase inhibitory activity of Cosmos caudatus at different growth stages. BMC Complement. Altern. Med. 2019, 19, 245. [Google Scholar] [CrossRef] [Green Version]
  55. Arung, E.T.; Furuta, S.; Ishikawa, H.; Kusuma, I.W.; Shimizu, K.; Kondo, R. Anti-melanogenesis properties of quercetin- and its derivative-rich extract from Allium cepa. Food Chem. 2011, 124, 1024–1028. [Google Scholar] [CrossRef]
  56. Bhullar, K.S.Z.; Warnakulasuriya, S.N.; Rupasinghe, H.P.V. Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin. Bioorganic Med. Chem. 2013, 21, 684–692. [Google Scholar] [CrossRef]
  57. Mehmood, A.; Ishaq, M.; Zhao, L.; Safdar, B.; Rehman, A.; Munir, M.; Raza, A.; Nadeem, M.; Iqbal, W.; Wang, C. Natural compounds with xanthine oxidase inhibitory activity: A review. Chem. Biol. Drug Des. 2019, 93, 387–418. [Google Scholar] [CrossRef] [PubMed]
  58. Liao, L.; Chen, J.; Liu, L.; Xiao, A. Screening and binding analysis of flavonoids with alpha-amylase inhibitory activity from lotus leaf. J. Braz. Chem. Soc. 2018, 29, 587–593. [Google Scholar] [CrossRef]
  59. Li, Y.Q.; Zhou, F.C.; Gao, F.; Bian, J.S.; Shan, F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase. J. Agric. Food Chem. 2009, 57, 11463–11468. [Google Scholar] [CrossRef]
  60. Aoyama, H.; Sakagami, H.; Hatano, T. Three new flavonoids, proanthocyanidin, and accompanying phenolic constituents from Feijoa sellowiana. Biosci. Biotechnol. Biochem. 2018, 82, 31–40. [Google Scholar] [CrossRef] [Green Version]
  61. Xu, R.; Bu, Y.G.; Zhao, M.L.; Tao, R.; Luo, J.; Li, Y. Studies on antioxidant and α-glucosidase inhibitory constituents of Chinese toon bud (Toona sinensis). J. Funct. Foods 2020, 73. [Google Scholar] [CrossRef]
  62. Jeong, C.H.; Shim, K.H. Tyrosinase inhibitor isolated from the leaves of Zanthoxylum piperitum. Biosci. Biotechnol. Biochem. 2004, 68, 1984–1987. [Google Scholar] [CrossRef] [Green Version]
  63. Aderogba, M.A.; Ndhlala, A.R.; Rengasamy, K.R.R.; Van Staden, J. Antimicrobial and selected in vitro enzyme inhibitory effects of leaf extracts, flavonols and indole alkaloids isolated from Croton menyharthii. Molecules 2013, 18, 12633–12644. [Google Scholar] [CrossRef]
  64. Nithitanakool, S.; Pithayanukul, P.; Bavovada, R.; Saparpakorn, P. Molecular docking studies and anti-tyrosinase activity of thai mango seed kernel extract. Molecules 2009, 14, 257–265. [Google Scholar] [CrossRef] [Green Version]
  65. Kim, Y.J. Antimelanogenic and antioxidant properties of gallic acid. Biol. Pharm. Bull. 2007, 30, 1052–1055. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Choudhary, D.K.; Mishra, A. In vitro and in silico interaction of faba bean (Vicia faba L.) seed extract with xanthine oxidase and evaluation of antioxidant activity as a therapeutic potential. Nat. Prod. Res. 2019, 33, 2689–2693. [Google Scholar] [CrossRef] [PubMed]
  67. Kam, A.; Li, K.M.; Razmovski-Naumovski, V.; Nammi, S.; Shi, J.; Chan, K.; Li, G.Q. A comparative study on the inhibitory effects of different parts and chemical constituents of pomegranate on α-amylase and α-glucosidase. Phyther. Res. 2013, 27, 1614–1620. [Google Scholar] [CrossRef]
  68. Tang, H.; Cui, F.; Li, H.; Huang, Q.; Li, Y. Understanding the inhibitory mechanism of tea polyphenols against tyrosinase using fluorescence spectroscopy, cyclic voltammetry, oximetry, and molecular simulations. RSC Adv. 2018, 8, 8310–8318. [Google Scholar] [CrossRef] [Green Version]
  69. Suganthy, N.; Pandima Devi, K. In vitro antioxidant and anti-cholinesterase activities of Rhizophora mucronata. Pharm. Biol. 2016, 54, 118–129. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Nagao, A.; Seki, M.; Kobayashi, H. Inhibition of xanthine oxidase of flavonoids. Biosci. Biotechnol. Biochem. 1999, 63, 1787–1790. [Google Scholar] [CrossRef]
  71. Júnior, J.P.L.; de Franco, R.R.; Saraiva, A.L.; Moraes, I.B.; Espindola, F.S. Anacardium humile St. Hil as a novel source of antioxidant, antiglycation and α-amylase inhibitors molecules with potential for management of oxidative stress and diabetes. J. Ethnopharmacol. 2021, 268. [Google Scholar] [CrossRef]
  72. Zhao, L.; Wen, L.; Lu, Q.; Liu, R. Interaction mechanism between α-glucosidase and A-type trimer procyanidin revealed by integrated spectroscopic analysis techniques. Int. J. Biol. Macromol. 2020, 143, 173–180. [Google Scholar] [CrossRef] [PubMed]
  73. Wang, Z.; Hwang, S.H.; Huang, B.; Lim, S.S. Identification of tyrosinase specific inhibitors from Xanthium strumarium fruit extract using ultrafiltration-high performance liquid chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2015, 1002, 319–328. [Google Scholar] [CrossRef]
  74. Strzępek-Gomółka, M.; Gaweł-Bęben, K.; Angelis, A.; Antosiewicz, B.; Sakipova, Z.; Kozhanova, K.; Głowniak, K.; Kukula-Koch, W. Identification of mushroom and murine tyrosinase inhibitors from achillea biebersteinii Afan. Extract. Molecules 2021, 26, 964. [Google Scholar] [CrossRef] [PubMed]
  75. Nguyen, M.T.T.; Awale, S.; Tezuka, Y.; Le Tran, Q.; Watanabe, H.; Kadota, S. Xanthine oxidase inhibitory activity of vietnamese medicinal plants. Biol. Pharm. Bull. 2004, 27, 1414–1421. [Google Scholar] [CrossRef] [Green Version]
  76. Olennikov, D.N.; Kashchenko, N.I. Componential profile and amylase inhibiting activity of phenolic compounds from Calendula officinalis L. leaves. Sci. World J. 2014, 2014. [Google Scholar] [CrossRef] [Green Version]
  77. Ooi, K.L.; Muhammad, T.S.T.; Tan, M.L.; Sulaiman, S.F. Cytotoxic, apoptotic and anti-α-glucosidase activities of 3,4-di-O-caffeoyl quinic acid, an antioxidant isolated from the polyphenolic-rich extract of Elephantopus mollis Kunth. J. Ethnopharmacol. 2011, 135, 685–695. [Google Scholar] [CrossRef]
  78. Park, S.; Jegal, J.; Chung, K.W.; Jung, H.J.; Noh, S.G.; Chung, H.Y.; Ahn, J.; Kim, J.; Yang, M.H. Isolation of tyrosinase and melanogenesis inhibitory flavonoids from Juniperus chinensis fruits. Biosci. Biotechnol. Biochem. 2018, 82, 2041–2048. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Pintus, F.; Spanò, D.; Corona, A.; Medda, R. Antityrosinase activity of Euphorbia characias extracts. PeerJ 2015, 2015. [Google Scholar] [CrossRef]
  80. Tsatsop Tsague, R.K.T.; Kenmogne, S.B.; Tchienou, G.E.D.; Parra, K.; Ngassoum, M.B. Sequential extraction of quercetin-3-O-rhamnoside from Piliostigma thonningii Schum. leaves using microwave technology. SN Appl. Sci. 2020, 2, 1230. [Google Scholar] [CrossRef]
  81. Arima, H.; Danno, G.I. Isolation of antimicrobial compounds from guava (psidium guajava L.) and their structural elucidation. Biosci. Biotechnol. Biochem. 2002, 66, 1727–1730. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Jabir, N.R.; Khan, F.R.; Tabrez, S. Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of alzheimer’s disease. CNS Neurosci. Ther. 2018, 24, 753–762. [Google Scholar] [CrossRef]
  83. Szwajgier, D.; Borowiec, K. Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitors. J. Inst. Brew. 2012, 118, 40–48. [Google Scholar] [CrossRef]
  84. Dizdar, M.; Vidic, D.; Požgan, F.; Štefane, B.; Maksimović, M. Acetylcholinesterase inhibition and antioxidant activity of N-trans-caffeoyldopamine and N-trans-feruloyldopamine. Sci. Pharm. 2018, 86, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Oboh, G.; Ogunsuyi, O.B.; Ogunbadejo, M.D.; Adefegha, S.A. Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose. J. Food Drug Anal. 2016, 24, 627–634. [Google Scholar] [CrossRef] [PubMed]
  86. Mathew, S.; Abraham, T.E.; Zakaria, Z.A. Reactivity of phenolic compounds towards free radicals under in vitro conditions. J. Food Sci. Technol. 2015, 52, 5790–5798. [Google Scholar] [CrossRef] [Green Version]
  87. Park, H.; Kim, S.; Kim, S.; Song, Y.; Seung, K.; Hong, D.; Khang, G.; Lee, D. Antioxidant and anti-inflammatory activities of hydroxybenzyl alcohol releasing biodegradable polyoxalate nanoparticles. Biomacromolecules 2010, 11, 2103–2108. [Google Scholar] [CrossRef] [PubMed]
  88. Groussard, C.; Morel, I.; Chevanne, M.; Monnier, M.; Cillard, J.; Delamarche, A. Free radical scavenging and antioxidant effects of lactate ion: An in vitro study. J. Appl. Physiol. 2000, 89, 169–175. [Google Scholar] [CrossRef]
  89. Zheng, Y.Z.; Deng, G.; Liang, Q.; Chen, D.F.; Guo, R.; Lai, R.C. Antioxidant activity of quercetin and its glucosides from propolis: A theoretical study. Sci. Rep. 2017, 7, 7543. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Iacopini, P.; Baldi, M.; Storchi, P.; Sebastiani, L. Catechin, epicatechin, quercetin, rutin and resveratrol in red grape: Content, in vitro antioxidant activity and interactions. J. Food Compos. Anal. 2008, 21, 589–598. [Google Scholar] [CrossRef]
  91. Razavi, S.M.; Zahri, S.; Zarrini, G.; Nazemiyeh, H.; Mohammadi, S. Biological activity of quercetin-3-O-glucoside, a known plant flavonoid. Russ. J. Bioorganic Chem. 2009, 35, 376–378. [Google Scholar] [CrossRef]
  92. Zhao, M.H.; Jiang, Z.T.; Liu, T.; Li, R. Flavonoids in Juglans regia L. leaves and evaluation of in vitro antioxidant activity via intracellular and chemical methods. Sci. World J. 2014, 2014. [Google Scholar] [CrossRef] [Green Version]
  93. Materska, M.; Perucka, I. Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L.). J. Agric. Food Chem. 2005, 53, 1750–1756. [Google Scholar] [CrossRef]
  94. Liu, Z.; Tao, X.; Zhang, C.; Lu, Y.; Wei, D. Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. Biomed. Pharmacother. 2005, 59, 481–490. [Google Scholar] [CrossRef]
  95. Hung, T.M.; Na, M.K.; Thuong, P.T.; Su, N.D.; Sok, D.E.; Song, K.S.; Seong, Y.H.; Bae, K.H. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J. Ethnopharmacol. 2006, 108, 188–192. [Google Scholar] [CrossRef]
  96. Jun, Y.L.; Eun, J.C.; Hyo, J.K.; Jun, H.P.; Sang, W.C. Antioxidative flavonoids from leaves of Carthamus tinctorius. Arch. Pharm. Res. 2002, 25, 313–319. [Google Scholar] [CrossRef]
  97. Kilic, I.; Yeşiloǧlu, Y.; Bayrak, Y. Spectroscopic studies on the antioxidant activity of ellagic acid. Spectrochim. Acta Part. A Mol. Biomol. Spectrosc. 2014, 130, 447–452. [Google Scholar] [CrossRef] [PubMed]
  98. Zhou, D.Y.; Sun, Y.X.; Shahidi, F. Preparation and antioxidant activity of tyrosol and hydroxytyrosol esters. J. Funct. Foods 2017, 37, 66–73. [Google Scholar] [CrossRef]
  99. Babaei, H.; Sadeghpour, O.; Nahar, L.; Delazar, A.; Nazemiyeh, H.; Mansouri, M.R.; Poursaeid, N.; Asnaashari, S.; Moghadam, S.B.; Sarker, S.D. Antioxidant and vasorelaxant activities of flavonoids from Amygdalus lycioides var. horrida. Turkish J. Biol. 2008, 32, 203–208. [Google Scholar]
  100. Nazemiyeh, H.; Kazemi, E.M.; Zare, K.; Jodari, M.; Nahar, L.; Sarker, S.D. Free radical scavengers from the aerial parts of Euphorbia petiolata. J. Nat. Med. 2010, 64, 187–190. [Google Scholar] [CrossRef]
  101. Kumar, S.; Prahalathan, P.; Raja, B. Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: A dose-dependence study. Redox Rep. 2011, 16, 208–215. [Google Scholar] [CrossRef] [PubMed]
  102. Chethan, S.; Dharmesh, S.M.; Malleshi, N.G. Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols. Bioorganic Med. Chem. 2008, 16, 10085–10090. [Google Scholar] [CrossRef] [PubMed]
  103. Kiliç, I.; Yeşiloǧlu, Y. Spectroscopic studies on the antioxidant activity of p-coumaric acid. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2013, 115, 719–724. [Google Scholar] [CrossRef]
  104. Kikuzaki, H.; Hisamoto, M.; Hirose, K.; Akiyama, K.; Taniguchi, H. Antioxidant properties of ferulic acid and its related compounds. J. Agric. Food Chem. 2002, 50, 2161–2168. [Google Scholar] [CrossRef] [PubMed]
  105. Gülçin, I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006, 217, 213–220. [Google Scholar] [CrossRef]
  106. Gordon, M.H.; Roedig-Penman, A. Antioxidant activity of quercetin and myricetin in liposomes. Chem. Phys. Lipids 1998, 97, 79–85. [Google Scholar] [CrossRef]
  107. Pekkarinen, S.S.; Heinonen, I.M.; Hopia, A.I. Flavonoids quercetin, myricetin, kaemferol and (+)-catechin as antioxidants in methyl linoleate. J. Sci. Food Agric. 1999, 79, 499–506. [Google Scholar] [CrossRef]
  108. Áy, É.; Hunyadi, A.; Mezei, M.; Minárovits, J.; Hohmann, J. Flavonol 7-O-glucoside herbacitrin inhibits HIV-1 replication through simultaneous integrase and reverse transcriptase inhibition. Evid. Based Complement. Altern. Med. 2019, 2019. [Google Scholar] [CrossRef] [Green Version]
  109. Mahmood, N.; Pizza, C.; Aquino, R.D.; Tommasi, N.; Piacente, S.; Colman, S.B.A.S.; Hay, A.J. Inhibition of HIV infection by flavanoids. Antiviral Res. 1993, 22, 189–199. [Google Scholar] [CrossRef]
  110. Kratz, J.M.; Andrighetti-Fröhner, C.R.; Kolling, D.J.; Leal, P.C.; Cirne-Santos, C.C.; Yunes, R.A.; Nunes, R.J.; Trybala, E.; Bergström, T.; Frugulhetti, I.C.P.P.; et al. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem. Inst. Oswaldo Cruz 2008, 103, 437–442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  111. Wijaya, S.J.; Yanuar, A.; Handayani, R.; Syahdi, R.R. In silico analysis of flavonoid glycosides and its aglycones as reverse transcriptase inhibitor. Pharmacogn. J. 2019, 11, 1252–1255. [Google Scholar] [CrossRef]
  112. Akroum, S.; Bendjeddou, D.; Satta, D.; Lalaoui, K. Antibacterial activity and acute toxicity effect of flavonoids extracted from mentha longifolia. Am. J. Sustain. Agric. 2009, 4, 93–96. [Google Scholar]
  113. Rattanachaikunsopon, P.; Phumkhachorn, P. Contents and antibacterial activity of flavonoids extracted from leaves of Psidium guajava. J. Med. Plants Res. 2010, 4, 393–396. [Google Scholar]
  114. Gutiérrez-Larraínzar, M.; Rúa, J.; Caro, I.; de Castro, C.; de Arriaga, D.; García-Armesto, M.R.; del Valle, P. Evaluation of antimicrobial and antioxidant activities of natural phenolic compounds against foodborne pathogens and spoilage bacteria. Food Control. 2012, 26, 555–563. [Google Scholar] [CrossRef]
  115. Rawdkuen, S. Antimicrobial activity of some potential active compounds against food spoilage microorganisms. African J. Biotechnol. 2012, 11, 13914–13921. [Google Scholar] [CrossRef] [Green Version]
  116. Guzman, J.D. Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules 2014, 19, 19292–19349. [Google Scholar] [CrossRef]
  117. Borges, A.; Ferreira, C.; Saavedra, M.J.; Simões, M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. Microb. Drug Resist. 2013, 19, 256–265. [Google Scholar] [CrossRef]
  118. Giordani, R.; Trebaux, J.; Masi, M.; Regli, P. Enhanced antifungal activity of ketoconazole by Euphorbia characias latex against Candida albicans. J. Ethnopharmacol. 2001, 78, 1–5. [Google Scholar] [CrossRef]
  119. Martos, S.; Spanò, D.; Agustí, N.; Poschenrieder, C.; Pintus, F.; Moles, L.; Medda, R. A chitinase from Euphorbia characias latex is a novel and powerful plant-based pesticide against Drosophila suzukii. Ann. Appl. Biol. 2017, 171, 252–263. [Google Scholar] [CrossRef]
Plants 10 01468 g001 550
Figure 1. The Mediterranean shrub E. characias. Leaves and characteristic flowers are visible in the imagine on the left (a), while (b) clearly shows the milky latex that exudes from the cut branch of the plant (imagine modified from reference [4]).
Figure 1. The Mediterranean shrub E. characias. Leaves and characteristic flowers are visible in the imagine on the left (a), while (b) clearly shows the milky latex that exudes from the cut branch of the plant (imagine modified from reference [4]).
Plants 10 01468 g001
Plants 10 01468 g002 550
Figure 2. Triterpenes, sterols and sesquiterpenes identified from E. characias latex (compounds 19, 20, 22, 24, 25, 28, 31–36) [18], seeds (compounds 20, 22–24, 26, 27) [24] and aerial parts (compounds 19–26, 28–30, 35–37) [25,27].
Figure 2. Triterpenes, sterols and sesquiterpenes identified from E. characias latex (compounds 19, 20, 22, 24, 25, 28, 31–36) [18], seeds (compounds 20, 22–24, 26, 27) [24] and aerial parts (compounds 19–26, 28–30, 35–37) [25,27].
Plants 10 01468 g002
Plants 10 01468 g003a 550Plants 10 01468 g003b 550
Figure 3. Phenolic compounds identified from E. characias latex (compounds 73, 74) [30] and aerial parts (compounds 74–89) [25,31,32,33].
Figure 3. Phenolic compounds identified from E. characias latex (compounds 73, 74) [30] and aerial parts (compounds 74–89) [25,31,32,33].
Plants 10 01468 g003aPlants 10 01468 g003b
Table
Table 1. Diterpenoids identified from aerial parts (leaves and stems) (compounds 1–10, 12–14) [12] and latex (compounds 11,15) [18] of E. characias: structure of ent-abietanes, ent-atisanes, ent-kauranes, ent-pimaranes and cembrene.
Table 1. Diterpenoids identified from aerial parts (leaves and stems) (compounds 1–10, 12–14) [12] and latex (compounds 11,15) [18] of E. characias: structure of ent-abietanes, ent-atisanes, ent-kauranes, ent-pimaranes and cembrene.
StructureCompound
ent-abietanes-1
Plants 10 01468 i0011 8α,14-dihydro-7-oxojolkinolide E
R = H
2 caudicifolin
R = OH
(8α,14-dihydro-7-oxohelioscopinolide A)
ent-abietanes-2
Plants 10 01468 i0023 jolkinolide E
R1 = R2 = H
(ent-abieta-8(14),13(15)-dien-16,12-olide)
4 helioscopinolide A
R1 = OH; R2 = H
5 helioscopinolide B
R1 = H; R2 = OH
Plants 10 01468 i0036 helioscopinolide E
ent-atisanes
Plants 10 01468 i0047 ent-2-hydroxyatisa-1,16(17)-diene-3,14-dione
Plants 10 01468 i005                                                                        R    R1
8 ent-atis-16(17)-ene-3,14-dione                    H   C=O
9 ent-3α-hydroxyatis-16(17)-ene-2,14-dione C=O OH
ent-kauranes
Plants 10 01468 i00610 16β,17-dihydroxy-ent-kauran-3-one
ent-pimaranes
Plants 10 01468 i00711 kaurene
Plants 10 01468 i00812 ent-pimara-8(14),15-dien-3α-ol
Plants 10 01468 i009                                                                           R    R1
13 3β,15,16-triacetoxy-ent-pimar-8(14)-ene      H    OAc
14 3β,15,16-triacetoxy-ent-pimar-8(14)-en-2-one       C=O  OAc
cembranes
Plants 10 01468 i01015 cembrene
Table
Table 2. Lathyranes and jatrophanes identified from E. characias latex (compounds 16a–f and 17a–f) [19,20], roots (compounds 17g–h) and whole plant (compounds 18a–l) [21].
Table 2. Lathyranes and jatrophanes identified from E. characias latex (compounds 16a–f and 17a–f) [19,20], roots (compounds 17g–h) and whole plant (compounds 18a–l) [21].
SchemeCompound
lathyranes
Plants 10 01468 i01116a 15-O-acetyl-3-O-propionyljolkiol-5β,6β-oxide)
R1 = COCH2Me; R2 = COMe; R3 = Me; R4 = H;
16b 15-O-acetyl-3-O-iso-butyryljolkiol-5β,6β-oxide)
R1 = COCHMe2; R2 = COMe; R3 = Me; R4 = H;
16c 15-O-acetyl-3-O-tigloyljolkiol-5β,6β-oxide)
R1 = COC(Me) ECHMe; R2 = COMe; R3 = Me; R4 = H;
16d 15-O-acetyl-3-O-benzoyljolkiol-5β,6β-oxide)
R1 = COC6H5; R2 = COMe; R3 = Me; R4 = H;
16e 15-O-acetyl-3-O-nicotinoyljolkiol-5β,6β-oxide)
R1 = COC5H4N; R2 = COMe; R3 = Me; R4 = H;
16f 2α-O-acetyl-3-O-iso-butyryl-15-O-nicotinoyljolkinol-5β,6β-oxide
R1 = COCHMe2; R2 = COC5H4N; R3 = Me; R4 = OCOMe
jatrophanes
Plants 10 01468 i01217a 15-O-acetyl-3-O-tigloylcharaciol-5β,6β-oxide)
R1 = tigloyl (COC(Me) ECHMe); R2 = COCH3;
17b 15-O-acetyl-3-O-benzoylcharaciol-5β,6β-oxide)
R1 = benzoyl (COC6H5); R2 = COCH3
Plants 10 01468 i01317c 15-O-acetyl-3-O-propionylcharaciol
R1 = propionyl (COCH2Me); R2 = COCH3
Plants 10 01468 i01417d 15-O-acetyl-5β-hydroxyisocharaciol-3-iso-butyrate)
R1 = iso-butyryl-(COCHMe2); R2 = COCH3;
17e 15-O-acetyl-5β-hydroxyisocharaciol-3-tigliate
R1 = tigloyl (COC(Me) ECHMe); R2 = COCH3;
17f 15-O-acetyl-5β-hydroxyisocharaciol-3-benzoate
R1 = benzoyl (COC6H5); R2 = COCH3
Plants 10 01468 i01517g 2,5,8,15-O-triacetyl, nicotinoyl-2,5β,8-trihydroxyisocharaciol-3-benzoate
R = acetyl (x 3), benzoyl, nicotinoyl;
17h 2,5,8,15-O-triacetyl, nicotinoyl-2,5β,8-trihydroxyisocharaciol-3-tigliate
R = acetyl (x 3), tigloyl, nicotinoyl;
Plants 10 01468 i01618a-l euphocharacin
18a R1 = OH; R2 = Bz; R3 = Ac; R4 = Nic; R5 = Ac
18b R1 = OH; R2 = Bz; R3 = Ac; R4 = Nic; R5 = H
18c R1 = OH; R2 = Bz; R3 = Ac; R4 = Bz; R5 = H
18d R1 = OH; R2 = MeBu; R3 = Ac; R4 = Nic; R5 = Ac
18e R1 = H; R2 = Bz; R3 = Ac; R4 = Nic; R5 = H
18f R1 = H; R2 = Bz; R3 = Ac; R4 = Nic; R5 = Ac
18g R1 = H; R2 = iBu; R3 = Ac; R4 = Nic; R5 = H
18h R1 = H; R2 = iBu; R3 = Ac; R4 = Nic; R5 = Ac
18i R1 = H; R2 = Pr; R3 = Ac; R4 = Nic; R5 = Ac
18j R1 = H; R2 = Ac; R3 = Ac; R4 = Nic; R5 = Ac
18k R1 = H; R2 = iBu; R3 = H; R4 = Nic; R5 = Ac
18l R1 = OH; R2 = Bz; R3 = H; R4 = Nic; R5 = Ac
Pr = propionyl; iBu = isobutiryl; MeBu = 2-methylbutiryl; Bz = benzoyl;
Nic = nicotinoyl
Table
Table 3. Cerebrosides identified from the latex of E. characias (compounds 47–55).
Table 3. Cerebrosides identified from the latex of E. characias (compounds 47–55).
cerebrosides 47–50 [28]
Plants 10 01468 i017
47 (2S, 3S, 4R, 5R, 6Z)-l-O-(β-d-glucopyranosyl)-2-N-[2′R)-2′-hydroxy-(15′Z)-tetracosenoylamino]-6(Z)-octadecene-l,3,4,5-tetraol
48 (2S, 3S, 4R, 5R, 6Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxy-(17′Z)-hexacosenoy1amino]-6(Z)-octadecene-l,3,4,5-tetraol
49 (2S, 3S, 4R, 5R, 6Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxy-(19′Z)-octacosenoylamino]-6(Z)-octadecene-l,3,4,5-tetraol
50 (2S, 3S, 4R, 5R, 6Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxyoctacosanoylamino]-(Z)-octadecene-l,3,4,5-tetraol
cerebrosides 51–55 [29]
Plants 10 01468 i018
51 (2S, 3S, 4R, 8Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxy-(15′Z)-tetracosenoylamino]-8(Z)-octadecene-1,3,4-triol
52 (2S, 3S, 4R, 8Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxy-(17′Z)-hexacosenoyl]-8(Z)-octadecene-1,3,4-triol
53 (2S, 3S, 4R, 8Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxy-(19′Z)-octacosenoylamino]-8(Z)-octadecene-l,3,4-triol
54 (2S, 3S, 4R, 8Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxyhexacosanoylamino]-8(Z)-octadecene-1,3,4-triol
55 (2S, 3S, 4R, 8Z)-l-O-(β-d-glucopyranosyl)-2-N-[(2′R)-2′-hydroxyheptacosanoylamino]-8(Z)-octadecene-l,3,4-triol
Table
Table 4. Other compounds (90–121) identified from aerial parts of E. characias.
Table 4. Other compounds (90–121) identified from aerial parts of E. characias.
CompoundPart of the PlantReference
heptacosane 90Stems[25]
nonacosane 91Leaves, Stems[25]
pentacosene 92
hentriacontane 93
triacontane 94
tritriacontane 95
heneicosane 96Flowers[34]
docosane 97
tricosane 98
pentacosane 99
heptacosane 100
nonacosane 101
phytol 102Leaves, Flowers[25,34]
tetracosanol 103Stems[25]
hexacosanol 104Leaves, Stems[25]
octacosanol 105
inositol 106
myo-inositol 107
octacosanal 108
nonanal 109Flowers[34]
tridecanal 110
tetradecanal 111
hexadecanal 112
hexacosanal 113
6,10,14-trimethyl-2-pentadecanone 114
farnesyl acetone 115
α-tocopherol 116Leaves[25]
hexadecanoic acid 117Flowers[34]
pyroglutamic acid 118Leaves, Stems[25]
D-glucose 119
D-fructose 120
sucrose 121
Table
Table 5. Inhibitory activities of E. characias extracts. The inhibitory activity is expressed as IC50 values. Kojic acid, galantamine, allopurinol and acarbose are reported as standard inhibitors. The mode of inhibition, when known, is shown in square brackets.
Table 5. Inhibitory activities of E. characias extracts. The inhibitory activity is expressed as IC50 values. Kojic acid, galantamine, allopurinol and acarbose are reported as standard inhibitors. The mode of inhibition, when known, is shown in square brackets.
Part of the Plant/Reference CompoundsExtractIC50 (µg/mL)
TyrosinaseAChEBChEXOα-Amylaseα-Glucosidase
LeavesWater120 ± 10
[mixed-type]		(4.2 ± 0.25) × 103NI>20074.02 ± 3.061.4 ± 0.11
Ethanol34 ± 2
[competitive]		600 ± 56390 ± 4068.9 ± 6.6 [mixed-type]25.41 ± 1.42 [noncompetitive]0.8 ± 0.03 [noncompetitive]
StemsWater(1.80 ± 0.13) × 103(6.9 ± 0.71) × 103NI---
Ethanol(1.10 ± 0.090) × 103(5.8 ± 0.43) × 103NI---
FlowersWater490 ± 25(5.25 ± 0.35) × 103(4.20 ± 0.39) × 103>200109.12 ± 10.361.1 ± 0.07
Ethanol150 ± 11600 ± 56(1.22 ± 0.08) × 10385.5 ± 6.4 [mixed-type]29.39 ± 1.41 [noncompetitive]0.9 ± 0.04 [uncompetitive]
Kojic acid 0.8 ± 0.03-----
Galantamine -0.27 ± 0.078.12 ± 0.61---
Allopurinol ---0.012--
Acarbose ----8.04 ± 0.6590 ± 7.3
NI: no inhibition.
Table
Table 6. Compounds identified in E. characias flower and leaf ethanolic extracts with referred inhibitory activity.
Table 6. Compounds identified in E. characias flower and leaf ethanolic extracts with referred inhibitory activity.
CompoundTyrosinaseAChEBChEXOα-Amylaseα-Glucosidase
quercetin 74[40,41,42][43,44,45,46][43,44,46,47][48,49][50,51][50,52,53,54]
quercetin-3-O-glucoside 75[41,55,56]--[57][58][59]
quercetin-3-O-xyloside 76[60]-----
quercetin-3-O-arabinoside 77[60]----[61]
quercetin-3-O-rhamnoside 78[62][63]---[52]
gallic acid 81[64,65][46][46][66]NI [67][67]
catechin 82[68][69][69][70][71][72]
di-O-caffeoylquinic acid 84[73,74]--[75][76][77]
kaempferol-3-O-arabinoside 88-----[61]
kaempferol-3-O-rhamnoside 89[78][63]---[61]
NI = no inhibition.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fais, A.; Delogu, G.L.; Floris, S.; Era, B.; Medda, R.; Pintus, F. Euphorbia characias: Phytochemistry and Biological Activities. Plants 2021, 10, 1468. https://doi.org/10.3390/plants10071468

AMA Style

Fais A, Delogu GL, Floris S, Era B, Medda R, Pintus F. Euphorbia characias: Phytochemistry and Biological Activities. Plants. 2021; 10(7):1468. https://doi.org/10.3390/plants10071468

Chicago/Turabian Style

Fais, Antonella, Giovanna Lucia Delogu, Sonia Floris, Benedetta Era, Rosaria Medda, and Francesca Pintus. 2021. "Euphorbia characias: Phytochemistry and Biological Activities" Plants 10, no. 7: 1468. https://doi.org/10.3390/plants10071468

APA Style

Fais, A., Delogu, G. L., Floris, S., Era, B., Medda, R., & Pintus, F. (2021). Euphorbia characias: Phytochemistry and Biological Activities. Plants, 10(7), 1468. https://doi.org/10.3390/plants10071468

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop